LAG3 and neoplasm: In pancreatic ductal adenocarcinoma, Galectin-3 was shown to engage CD8+ T cells coexpressing PD-1 and LAG3 in the tumor microenvironment, although coimmunoprecipitation experiments confirmed binding to LAG3 but not PD-1 (24).